Remote group sessions may hold key to long-term smoking abstinence

NCT ID NCT06746025

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests a structured, 8-week smoking cessation program delivered via weekly video group sessions. It enrolls adults addicted to nicotine who want to quit. Researchers track whether participants stay smoke-free six months after the program ends, and how their anxiety and trigger management change.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the program proves effective, it could offer a scalable, remote option to help people quit smoking and reduce nicotine addiction.
What could go wrong
This is an observational study without a control group, so results may not prove the program causes abstinence. Success depends on participant commitment and may not generalize to all smokers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

371 people

The number who actually took part.

Started

Oct 2024

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study, although offered without geographical limitations, will be limited to United States residents

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. must be addicted to nicotine either by cigarette or vaping 2. must have access to an internet connected device, laptop, or smartphone 3. must be 18 years old or older Exclusion Criteria: 1. currently enrolled in any weight-loss program 2. currently enrolled in any behavioral modification program 3. currently using nicotine replacement therapy of any kind

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nicotine addiction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive nicotine dependence Smoking Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • QuitCenter.org

    Naples, Florida, 34104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.